Literature DB >> 31141691

Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation.

Jieqiong Zhang1, Joshua D Webster2, Debra L Dugger1, Tatiana Goncharov3, Merone Roose-Girma4, Jeffrey Hung2, Youngsu C Kwon5, Domagoj Vucic3, Kim Newton6, Vishva M Dixit7.   

Abstract

Cellular inhibitor of apoptosis proteins cIAP1 and cIAP2 ubiquitinate nuclear factor κB (NF-κB)-inducing kinase (NIK) to suppress non-canonical NF-κB signaling and substrates such as receptor interacting protein kinase 1 (RIPK1) to promote cell survival. We investigate how these functions contribute to homeostasis by eliminating cIap2 from adult cIap1-deficient mice. cIAP1 and cIAP2 (cIAP1/2) deficiency causes rapid weight loss and inflammation, with aberrant cell death, indicated by cleaved caspases-3 and -8, prevalent in intestine and liver. Deletion of Casp8 and Ripk3 prevents this aberrant cell death, reduces the inflammation, and prolongs mouse survival, whereas Ripk3 loss alone offers little benefit. Residual inflammation in mice lacking cIap1/2, Casp8, and Ripk3 is reduced by inhibition of NIK. Loss of Casp8 and Mlkl (mixed lineage kinase domain-like), but not Mlkl loss alone, also prevents cIAP1/2-deficient mice from dying around embryonic day 11. Therefore, a major function of cIAP1/2 in vivo is to suppress caspase-8-dependent cell death.
Copyright © 2019 Genentech. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NIK; apoptosis; cIAP1; cIAP2; caspase-8

Year:  2019        PMID: 31141691     DOI: 10.1016/j.celrep.2019.04.111

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  20 in total

1.  Caspases in Cell Death, Inflammation, and Pyroptosis.

Authors:  Sannula Kesavardhana; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Annu Rev Immunol       Date:  2020-02-04       Impact factor: 28.527

2.  Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer.

Authors:  Chunyan Liu; Zhaobo Chen; Xiaoyan Ding; Yun Qiao; Bing Li
Journal:  Lab Invest       Date:  2022-01-12       Impact factor: 5.662

Review 3.  Programming inflammatory cell death for therapy.

Authors:  Shelbi Christgen; Rebecca E Tweedell; Thirumala-Devi Kanneganti
Journal:  Pharmacol Ther       Date:  2021-10-04       Impact factor: 12.310

4.  Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis.

Authors:  Debolina D Biswas; Rebecca K Martin; LaShardai N Brown; Karli Mockenhaupt; Angela S Gupta; Michael J Surace; Anuj Tharakan; Jessie W Yester; Reetika Bhardwaj; Daniel H Conrad; Tomasz Kordula
Journal:  J Neuroinflammation       Date:  2022-06-19       Impact factor: 9.587

Review 5.  NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis.

Authors:  Bingran Wang; Jun Shen
Journal:  Front Immunol       Date:  2022-06-27       Impact factor: 8.786

Review 6.  Beyond inflammasomes: emerging function of gasdermins during apoptosis and NETosis.

Authors:  Kaiwen W Chen; Benjamin Demarco; Petr Broz
Journal:  EMBO J       Date:  2019-12-03       Impact factor: 11.598

7.  Immunoblot Analysis of the Regulation of TNF Receptor Family-Induced NF-κB Signaling by c-IAP Proteins.

Authors:  Eugene Varfolomeev; Tatiana Goncharov; Domagoj Vucic
Journal:  Methods Mol Biol       Date:  2021

Review 8.  The regulation of necroptosis by post-translational modifications.

Authors:  Yanxiang Meng; Jarrod J Sandow; Peter E Czabotar; James M Murphy
Journal:  Cell Death Differ       Date:  2021-01-18       Impact factor: 15.828

9.  Bclaf1 regulates c-FLIP expression and protects cells from TNF-induced apoptosis and tissue injury.

Authors:  Rui Zhang; Teng Xue; Anwen Shao; Yue Lang; Chao Qin; Mingliang Zhao; Yu Kuang; Zhengquan Yu; Yunyun Geng; Chenyang Zhao; Jun Tang
Journal:  EMBO Rep       Date:  2021-10-25       Impact factor: 8.807

Review 10.  Small Molecule NF-κB Pathway Inhibitors in Clinic.

Authors:  Venkataramanan Ramadass; Thamilselvan Vaiyapuri; Vinay Tergaonkar
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.